검색어 : 통합검색[Vaughn Margaret]
총 196건 중 196건 출력
, 18/20 페이지
-
171
- Building a model to predict the risk of multiple severe neurotoxicities in cancer survivors after cisplatin treatment.
- Nakshatri, Swetha; Shuey, Megan; Shahbazi, Mohammad; Trendowski, Matthew; Dinh, Paul C.; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Fung, Chunkit; Kollmannsberger, Christian K.; Einhorn, Lawrence; Frisina, Robert D.; Travis, Lois B.; Dolan, Mary Eileen; Cox, Nancy; University of Chicago, Chicago, IL; ; Vanderbilt University Medical Center, Nashville, TN; ; University of Chicago, Chicago, IL; ; Wayne State University, Detroit, MI; ; Indiana University School of Medicine, Indianapolis, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada; ; University of Pennsylvania, Philadelphia, PA; ; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY; ; Department of Medicine, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Departments of Medical Engineering and Communication Sciences and Disorders, Global Center for Hearing and Speech Research, University of South Florida, Tampa, FL; ; Indiana University School of Medicine, Indianapolis, IN; ; Department of Medicine, University of Chicago, Chicago, IL; ; Vanderbilt University, Na; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.40, 2022, pp.e24066-e24066)
-
172
- Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus and peripheral sensory neuropathy.
- Zhang, Xindi; Trendowski, Matthew R.; Wilkinson, Emma; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Fung, Chunkit; Kollmannsberger, Christian K.; Huddart, Robert A; Martin, Neil E.; Dinh, Paul C; Frisina, Robert D.; Einhorn, Lawrence H.; Dolan, M. Eileen; Travis, Lois B.; Department of Medicine, University of Chicago, Chicago, IL; ; Department of Medicine, The University of Chicago, Chicago, IL; ; Department of Medicine, University of Chicago, Chicago, IL; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Division of Urologic Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Department of Medicine, University of Pennsylvania, Philadelphia, PA; ; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY; ; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; ; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; ; Dana-Farber Cancer Institute/Brigham & Women's Hospital, Boston, MA; ; Indiana University School of Medicine, Indianapolis, IN; ; Departments of Medical Engineering and Communication Sciences and Disorders, Global Center for Hearing and Speech Research, University of South Florida, Tampa, FL; ; Ind; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.39, 2021, pp.12004-12004)
-
173
- Cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study.
- Kerns, Sarah L.; Fung, Chunkit; Williams, AnnaLynn; Abu Zaid, Mohammad Issam; Sesso, Howard D.; Monahan, Patrick; Ardeshir-Rouhani-Fard, Shirin; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Sahasrabudhe, Deepak M.; Fossa, Sophie D.; Einhorn, Lawrence H.; Travis, Lois B.; University of Rochester Medical Center, Rochester, NY; ; Wilmot Cancer Center, Rochester, NY; ; University of Rochester School of Medicine and Dentistry, Rochester, NY; ; Indiana University School of Medicine, Indianapolis, IN; ; Division of Preventive Medicine, Harvard Medical School, Boston, MA; ; Indiana University School of Medicine, Indianapolis, IN; ; School of Public Health, Indiana University, Bloomington, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; ; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; ; Wilmot Cancer Center, Rochester, NY; ; Oslo University Hospital, University of Oslo, Oslo, Norway; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Department of Medical Oncology, Indiana University, Indianapolis, IN; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.10089-10089)
-
174
- Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors
- Kerns, Sarah L; Fung, Chunkit; Fossa, Sophie D; Dinh Jr, Paul C; Monahan, Patrick; Sesso, Howard D; Frisina, Robert D; Feldman, Darren R; Hamilton, Robert J; Vaughn, David; Martin, Neil; Huddart, Robert; Kollmannsberger, Christian; Sahasrabudhe, Deepak; Ardeshir-Rouhani-Fard, Shirin; Einhorn, Lawrence; Travis, Lois B; University of Rochester Medical Center , Rochester, NY, USA; University of Rochester Medical Center , Rochester, NY, USA; Oslo University Hospital , Oslo, Norway; Indiana University , Indianapolis, IN, USA; Indiana University , Indianapolis, IN, USA; Brigham and Women’s Hospital , Boston, MA, USA; University of South Florida , Tampa, FL, USA; Memorial Sloan Kettering Cancer Center , New York, NY, USA; Princess Margaret Cancer Center , Toronto, Canada; University of Pennsylvania , Philadelphia, PA, USA; Dana-Farber Cancer Institute , Boston, MA, USA; Royal Marsden Hospital , London, UK; University of British Columbia , Vancouver, British Columbia, Canada; University of Rochester Medical Center , Rochester, NY, USA; Indiana University , Indianapolis, IN, USA; Indiana University , Indianapolis, IN, USA; Indiana University , Indianapolis, IN, USA; (Jnci cancer spectrum, v.4, 2020, pp.pkaa022)
-
175
- Genome-wide association study (GWAS) of cisplatin-related hearing loss in testicular cancer survivors (TCS) to reveal associated variant in Wolfram syndrome 1 (WFS1) gene.
- Wheeler, Heather E.; Frisina, Robert D.; Gamazon, Eric R; El Charif, Omar; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Fung, Chunkit; Einhorn, Lawrence H.; Mushiroda, Taisei; Kubo, Michiaki; Cox, Nancy; Dolan, M. Eileen; Travis, Lois B.; Departments of Biology and Computer Science, Loyola University Chicago, Chicago, IL; ; University of South Florida, Tampa, FL; ; Vanderbilt University, Nashville, TN; ; University of Chicago, Chicago, IL; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; ; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; ; Wilmot Cancer Center, Rochester, NY; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; RIKEN Center for Integrative Medical Science, Yokohama, Japan; ; RIKEN Center for Integrative Medical Science, Yokohama, Japan; ; Vanderbilt University, Nashville, TN; ; University of Chicago, Chicago, IL; ; Department of Medical Oncology, Indiana University, Indianapolis, IN; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.10015-10015)
-
176
- Cardiovascular disease (CVD) risk factors and health behaviors following cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS).
- Abu Zaid, Mohammad Issam; Fung, Chunkit; Williams, AnnaLynn; Sesso, Howard D.; Kerns, Sarah L; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Liu, Hai; Fossa, Sophie D.; Einhorn, Lawrence H.; Travis, Lois B.; Indiana University School of Medicine, Indianapolis, IN; Wilmot Cancer Center, Rochester, NY; University of Rochester School of Medicine and Dentistry, Rochester, NY; Division of Preventive Medicine, Harvard Medical School, Boston, MA; University of Rochester Medical Center, Rochester, NY; Memorial Sloan Kettering Cancer Center, New York, NY; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; Indiana University School of Medicine, Indianapolis, IN; Oslo University Hospital, University of Oslo, Oslo, Norway; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; University of Rochester School of Medicine and Dentistry, Rochester, NY; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.129-129)
-
177
- Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
- Dolan, M. Eileen; El Charif, Omar; Wheeler, Heather E.; Gamazon, Eric R.; Ardeshir-Rouhani-Fard, Shirin; Monahan, Patrick; Feldman, Darren R.; Hamilton, Robert J.; Vaughn, David J.; Beard, Clair J.; Fung, Chunkit; Kim, Jeri; Fossa, Sophie D.; Hertz, Daniel L; Mushiroda, Taisei; Kubo, Michiaki; Einhorn, Lawrence H.; Cox, Nancy J.; Travis, Lois B.; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Medicine, University of Chicago, Chicago, Illinois.; Departments of Biology and Computer Science, Loyola University Chicago, Chicago, Illinois.; Division of Genetic Medicine, Vanderbilt University, Nashville, Tennessee.; Department of Medical Oncology, Indiana University, Indianapolis, Indiana.; Department of Medical Oncology, Indiana University, Indianapolis, Indiana.; Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.23, 2017, pp.5757-5768)
-
178
- Comprehensive characterization of cisplatin-related hearing loss in U.S. and Canadian Testicular Cancer Survivors (TCS).
- Wheeler, Heather E.; Travis, Lois B.; Budnick, Amy; Feldman, Darren Richard; Einhorn, Lawrence H.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Fung, Chunkit; Johnson, Eileen; Moore, Malcolm J.; Sahasrabudhe, Deepak M.; Fossa, Sophie D.; Sesso, Howard D.; Dolan, M. Eileen; Frisina, Robert D; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL; University of Rochester School of Medicine and Dentistry, Rochester, NY; Memorial Sloan Kettering Cancer Center, New York, NY; Memorial Sloan Kettering Cancer Center, New York, NY; Indiana University School of Medicine, Indianapolis, IN; University Health Network, Toronto, ON, Canada; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY; University of Rochester School of Medicine and Dentistry, Rochester, NY; Princess Margaret Cancer Centre, Toronto, ON, Canada; University of Rochester Wilmot Cancer Center, Rochester, NY; Oslo University Hospital and University of Oslo, Oslo, Norway; Harvard T.H. Chan School of Public Health, Boston, MA; University of Chicago, Chicago, IL; University of South Florida, Tampa, FL; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.9570-9570)
-
179
- Integration of a polygenic risk score of kidney function with cumulative cisplatin dose and time variables for the prediction of serum platinum levels.
- Shuey, Megan; Faucon, Annika; Trendowski, Matthew R.; Ratain, Mark J.; Dinh, Paul C; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Fung, Chunkit; Kollmannsberger, Christian K.; Huddart, Robert A; Martin, Neil E.; Hannigan, Robyn; Einhorn, Lawrence H.; Travis, Lois B.; Dolan, M. Eileen; Cox, Nancy; Vanderbilt University Medical Center, Nashville, TN; ; Vanderbilt University, Nashville, TN; ; Department of Medicine, The University of Chicago, Chicago, IL; ; University of Chicago, Chicago, IL; ; Indiana University School of Medicine, Indianapolis, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Division of Urologic Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Department of Medicine, University of Pennsylvania, Philadelphia, PA; ; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY; ; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; ; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; ; Dana Farber Cancer Institute, Boston, MA; ; Clarkson University, Potsdam, NY; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Department of Me; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.39, 2021, pp.12063-12063)
-
180
- Adverse health outcomes in relationship to hypogonadism (HG) after platinum-based chemotherapy: A multicenter study of North American testicular cancer survivors (TCS).
- Abu Zaid, Mohammad Issam; Menendez, Alvaro G.; El Charif, Omar; Fung, Chunkit; Monahan, Patrick O.; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Cook, Ryan; Althouse, Sandra K.; Sesso, Howard D.; Ardeshirrouhanifard, Shirin; Dinh, Paul C; Einhorn, Lawrence; Fosså , Sophie; Travis, Lois B.; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; The University of Chicago, Chicago, IL; ; University of Rochester Medical Center, Rochester, NY; ; Indiana University School of Medicine, Indianapolis, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center, Philadelphia, PA; ; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Division of Preventive Medicine, Harvard Medical School, Boston, MA; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; National Advisory Unit on Late Effects After Cancer Treatment, Oslo, Norway; ; Indiana University Scho; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.35, 2017, pp.LBA10012-LBA10012)
QUICK MENU
